US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 - Lu, Xiaoyan; Wang, Lijuan; Sakthivel, Senthilkumar K.; Whitaker, Brett; Murray, Janna; Kamili, Shifaq; Lynch, Brian; Malapati, Lakshmi; Burke, Stephen A.; Harcourt, Jennifer; Tamin, Azaibi; Thornburg, Natalie J.; et al. (Emerging infectious diseases, 2020)
Keywords: 2019 novel coronavirus disease; Betacoronavirus - genetics; Biomarkers - analysis; Centers for Disease Control and Prevention, U.S; coronavirus disease; Coronavirus Infections - diagnosis; Coronavirus Infections - virology; Coronavirus Nucleocapsid Proteins; Coronaviruses; COVID-19; Deoxyribonucleic acid; Disease control; DNA; DNA Primers - chemical synthesis; DNA Primers - genetics; Feces - virology; Fluoresceins - chemistry; Fluorescent Dyes - chemistry; Genetic aspects; Genomes; Health aspects; Humans; Limit of Detection; Medical laboratories; Nasopharynx - virology; Nucleocapsid Proteins - genetics; Pandemics; Phosphoproteins; Pneumonia, Viral - diagnosis; Pneumonia, Viral - virology; Polymerase chain reaction; Real-Time Polymerase Chain Reaction - methods; Real-Time Polymerase Chain Reaction - standards; Reproducibility of Results; Respiratory diseases; RNA; RNA polymerase; RNA, Viral - genetics; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Sputum - virology; Transcription (Genetics); United States; US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2; Viruses; United States; United States--US; China; COVID-19; SARS-CoV-2; viruses; severe acute respiratory syndrome coronavirus 2; zoonoses; 2019 novel coronavirus disease; coronavirus disease; real-time RT-PCR; real-time reverse transcription PCR; respiratory infections